MATSUEDA Satoko 松枝智子

… Alternative Names

松枝智子マツエダサトコ

Less

Researcher Number	60610582
Affiliation (Current)	2025: 久留米大学, 付置研究所, 講師
Affiliation (based on the past Project Information) *help	2016: 久留米大学, 先端がん治療研究センター, 講師 2013 – 2014: 久留米大学, がんワクチンセンター, 講師 2012: 久留米大学, 先端癌治療研究センター, 助教
Review Section/Research Field	Principal Investigator Digestive surgery Except Principal Investigator General surgery
Keywords	Principal Investigator がん / 液性免疫応答 / 細胞性免疫応答 / 免疫賦活 / がんペプチドワクチン / 免疫機能解析 / 免疫能解析 / 腫瘍関連抗原 / バイオマーカー / 生命予後 / ペプチド / 抗ペプチド抗体 … More Except Principal Investigator … More 免疫療法 / 個別化治療 / Ｔ細胞 / 免疫原性 / ネオアンチゲン / がん免疫療法 / 免疫反応 / 遺伝子変異 / 腫瘍免疫 Less

ペプチドワクチン療法における免疫抑制解除と免疫賦活の分子機構の解明Principal Investigator
- Principal Investigator
  
  松枝智子
- Project Period (FY)
  2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Digestive surgery
- Research Institution
  Kurume University
Comprehensive analysis of immune responses to tumor-specific genetic mutations and its application to novel cancer immunotherapy.
- Principal Investigator
  
  Sasada Tetsuro
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  General surgery
- Research Institution
  Kanagawa Cancer Center Research Institute
Analysis of immunoglobulins reactive to CTL epitopes peptidesPrincipal Investigator
- Principal Investigator
  
  MATSUEDA Satoko
- Project Period (FY)
  2012 – 2013
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Digestive surgery
- Research Institution
  Kurume University

All 2017 2016 2015 2014 2013 2012

All Journal Article Presentation

[Journal Article] Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11+ or -A33+ allele.2017
- Author(s)
  Sakamoto S, Matsueda S, Takamori S, Toh U, Noguchi M, Yutani S, Yamada A, Shichijo S, Yamada T, Suekane S, Kawano K, Naitou M, Sasada T, Hattori N, Kohno N, Itoh K.
- Journal Title
  
  Cancer Sci.
  
  Volume: 印刷中 Issue: 4 Pages: 598-603
- DOI
  10.1111/cas.13189
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-16K15601, KAKENHI-PROJECT-17K07229, KAKENHI-PROJECT-15H04831
[Journal Article] Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.2017
- Author(s)
  Sakamoto S, Yamada T, Terazaki Y, Yoshiyama K, Sugawara S, Takamori S, Matsueda S, Shichijo S, Yamada A, Noguchi M, Itoh K, Hattori N, Kohno N, Sasada T.
- Journal Title
  
  Clin Lung Cancer.
  
  Volume: 印刷中 Issue: 6 Pages: e385-e394
- DOI
  10.1016/j.cllc.2017.03.011
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-16K15601, KAKENHI-PROJECT-17K07229, KAKENHI-PROJECT-15H04831
[Journal Article] A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer.2017
- Author(s)
  Shirahama T, Muroya D, Matsueda S, Yamada A, Shichijo S, Naito M, Yamashita T, Sakamoto S, Okuda K, Itoh K, Sasada T, Yutani S.
- Journal Title
  
  Cancer Sci.
  
  Volume: 印刷中 Issue: 5 Pages: 838-845
- DOI
  10.1111/cas.13193
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-16K15601, KAKENHI-PROJECT-17K07229
[Journal Article] Enhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females.2017
- Author(s)
  Yokomine M, Matsueda S, Kawano K, Sasada T, Fukui A, Yamashita T, Komatsu N, Shichijo S, Tasaki K, Matsukuma K, Itoh K, Kamura T, Ushijima K.
- Journal Title
  
  Exp Ther Med.
  
  Volume: 13 Issue: 4 Pages: 1500-1505
- DOI
  10.3892/etm.2017.4150
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-16K15601
[Journal Article] n Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy.2016
- Author(s)
  Noguchi M, Matsumoto K, Uemura H, Arai G, Eto M, Naito S, Ohyama C, Nasu Y, Tanaka M, Moriya F, Suekane S, Matsueda S, Komatsu N, Sasada T, Yamada A, Kakuma T, Itoh K.
- Journal Title
  
  Clin Cancer Res
  
  Volume: 22 Issue: 1 Pages: 54-60
- DOI
  10.1158/1078-0432.ccr-15-1265
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26293353
[Journal Article] Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients.2016
- Author(s)
  Iwasa S, Yamada Y, Heike Y, Shoji H, Honma Y, Komatsu N, Matsueda S, Yamada A, Morita M, Yamaguchi R, Tanaka N, Kawahara A, Kage M, Shichijo S, Sasada T, Itoh K.
- Journal Title
  
  Cancer Sci.
  
  Volume: 印刷中 Issue: 5 Pages: 590-600
- DOI
  10.1111/cas.12919
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-16K19381
[Journal Article] A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer.2016
- Author(s)
  Noguchi M, Moriya F, Koga N, Matsueda S, Sasada T, Yamada A, Kakuma T, Itoh K.
- Journal Title
  
  Cancer Immunol Immunother.
  
  Volume: 65 Issue: 2 Pages: 151-60
- DOI
  10.1007/s00262-015-1781-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens.2015
- Author(s)
  Yamada T, Terazaki Y, Sakamoto S, Yoshiyama K, Matsueda S, Komatsu N, Waki K, Yamada A, Kawahara A, Kage M, Sugawara S, Yamashita Y, Sasada T, Takamori S, Itoh K.
- Journal Title
  
  Int J Oncol.
  
  Volume: 46 Issue: 1 Pages: 55-62
- DOI
  10.3892/ijo.2014.2699
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele.2015
- Author(s)
  Sakamoto S, Matsueda S, Takamori S, Toh U, Noguchi M, Yutani S, Yamada A, Shichijo S, Yamada T, Suekane S, Kawano K, Sasada T, Hattori N, Kohno N, Itoh K.
- Journal Title
  
  Cancer Sci.
  
  Volume: 106 Issue: 10 Pages: 1257-1263
- DOI
  10.1111/cas.12757
- NAID
  120006799352
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461965, KAKENHI-PROJECT-15H04831, KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castrate-resistant prostate cancer: dose-related immune boosting and suppression.2015
- Author(s)
  Noguchi M, Arai G, Matsumoto K, Naito S, Moriya F, Suekane S, Komatsu N, Matsueda S, Sasada T, Yamada A, Itoh K.
- Journal Title
  
  Cancer Immunol Immunother.
  
  Volume: 64 Issue: 4 Pages: 493-505
- DOI
  10.1007/s00262-015-1660-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592408, KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients.2015
- Author(s)
  Yutani S, Ueshima K, Abe K, Ishiguro A, Eguchi J, Matsueda S, Komatsu N, Shichijo S, Yamada A, Itoh K, Sasada T, Kudo M, Noguchi M.
- Journal Title
  
  J Immunol Res.
  
  Volume: 2015 Pages: 473909-473909
- DOI
  10.1155/2015/473909
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination.2015
- Author(s)
  Sakamoto S, Yoshitomi M, Yutani S, Terazaki Y, Yoshiyama K, Ioji T, Matsueda S, Yamada A, Takamori S, Itoh K, Hattori N, Kohno N, Sasada T.
- Journal Title
  
  Hum Vaccin Immunother.
  
  Volume: 11 Issue: 12 Pages: 2784-9
- DOI
  10.1080/21645515.2015.1075107
- NAID
  120006799351
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients.2014
- Author(s)
  Takahashi R, Toh U, Iwakuma N, Takenaka M, Otsuka H, Furukawa M, Fujii T, Seki N, Kawahara A, Kage M, Matsueda S, Akagi Y, Yamada A, Itoh K, Sasada T.
- Journal Title
  
  Breast Cancer Res.
  
  Volume: 16 Issue: 4 Pages: 00-00
- DOI
  10.1186/bcr3685
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23591914, KAKENHI-PROJECT-24591925, KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-26461965
[Journal Article] Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer.2014
- Author(s)
  Kibe S, Yutani S, Motoyama S, Nomura T, Tanaka N, Kawahara A, Yamaguchi T, Matsueda S, Komatsu N, Miura M, Hinai Y, Hattori S, Yamada A, Kage M, Itoh K, Akagi Y, Sasada T.
- Journal Title
  
  Cancer Immunol Res.
  
  Volume: 2 Issue: 12 Pages: 1154-1162
- DOI
  10.1158/2326-6066.cir-14-0035
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patients.2014
- Author(s)
  Kawano K, Tsuda N, Matsueda S, Sasada T, Watanabe N, Ushijima K, Yamaguchi T, Yokomine M, Itoh K, Yamada A, Kamura T.
- Journal Title
  
  Immunopharmacol Immunotoxicol.
  
  Volume: 36 Issue: 3 Pages: 224-236
- DOI
  10.3109/08923973.2014.913617
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine.2013
- Author(s)
  Yutani S, Komatsu N, Matsueda S, Yoshitomi M, Shirahama T, Yamada A, Itoh K, Sasada T.
- Journal Title
  
  Evid Based Complement Alternat Med.
  
  Volume: 2013 Pages: 981717-981717
- DOI
  10.1155/2013/981717
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-24791452
[Journal Article] Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: a new biomarker for overall survival of patients with malignant diseases.2013
- Author(s)
  Matsueda S, Komatsu N, Kusumoto K, Koga S, Yamada A, Kuromatsu R, Yamada S, Seki R, Yutani S, Shichijo S, Mine T, Fukuda T, Okamura T, Okuda S, Sata M, Honda J, Kaji M, Itoh K, Sasada T.
- Journal Title
  
  Dev Comp Immunol.
  
  Volume: 41(1) Issue: 1 Pages: 68-76
- DOI
  10.1016/j.dci.2013.04.004
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-24791452
[Presentation] The feasibility of personalized peptide vaccination for previously treated advanced colorectal cancer; A phase II Study.2015
- Author(s)
  Akagi Y, Kibe S, Yutani S, Motoyama S, Nomura T, Kawahara A, Yamaguchi T, Matsueda S, Komatsu N, Miura M, Hinai Y, Hattori S, Yamada A, Kage M, Itoh K, Sasada T.
- Organizer
  ESSR (European Society for Surgical Research) 2015.
- Place of Presentation
  Liverpool（England）
- Year and Date
  2015-06-10
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] Phase II Clinical Trial of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer.2014
- Author(s)
  Sasada T, Yutani S, Kibe S, Matsueda S, Komatsu K, Yamada A, Akagi Y, Itoh K.
- Organizer
  12th CIMT (The Association for Cancer Immunotherapy) Annual Meeting.
- Place of Presentation
  Mainz, Germany
- Year and Date
  2014-05-06
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] Randomized phase II study of personalized peptide vaccination with cyclophosphamide pretreatment in refractory advanced biliary tract cancer patients.2014
- Author(s)
  Sasada T, Yutani S, Matsueda S, Shirahama T, Yamada A, Itoh K.
- Organizer
  2014 ASCO Annual Meeting.
- Place of Presentation
  Chicago, IL, USA
- Year and Date
  2014-06-01
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans : A new biomarker for overall survival of patients with malignant diseases2013
- Author(s)
  Matsueda S, Komatsu N, Kusumoto K, Koga S, Yutani S, Shichijo S, Mine T, Itoh K, Sasada T
- Organizer
  The Cancer Vaccine Institute's International Symposium on Immunotherapy
- Place of Presentation
  イギリス・ロンドン
- Data Source
  KAKENHI-PROJECT-24791452
[Presentation] Humoral immune responses to CTL epitope peptides from tumor-associated antigens are are widely detectable in humans2013
- Author(s)
  Satoko Matsueda, Nobukazu Komatsu, Kenichi Kusumoto, Shintaro Koga, Shigeru Yutani, Shigeki Shichijo, Takashi Mine, Kyogo Itoh, Tetsuro Sasada
- Organizer
  The Cancer Vaccine Institute's International Symposium on Immunotherapy
- Place of Presentation
  英国、ロンドン
- Data Source
  KAKENHI-PROJECT-24791452
[Presentation] Antibodies against CTL epitopes from tumor-associated antigens are widely detectable in humans2012
- Author(s)
  Satoko Matsueda, Nobukazu Komatsu, Kenichi Kusumoto, Shintaro Koga, Shigeru Yutani, Shigeki Shichijo, Takashi Mine, Kyogo Itoh, Tetsuro Sasada
- Organizer
  癌学会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-24791452

1. Sasada Tetsuro (70293967)

# of Collaborated Projects: 1 results

# of Collaborated Products: 15 results
2. 田代康介 (00192170)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. MATSUMOTO Kazumasa

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
4. 関直子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
5. 唐宇飛

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
6. 山田亮

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
7. 伊東恭悟

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
8. 七條茂樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

MATSUEDA Satoko 松枝 智子

松枝 智子 マツエダ サトコ

Research Projects

Research Products

Co-Researchers

ペプチドワクチン療法における免疫抑制解除と免疫賦活の分子機構の解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Comprehensive analysis of immune responses to tumor-specific genetic mutations and its application to novel cancer immunotherapy.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of immunoglobulins reactive to CTL epitopes peptidesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11+ or -A33+ allele.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Enhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] n Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele.2015

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castrate-resistant prostate cancer: dose-related immune boosting and suppression.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination.2015

MATSUEDA Satoko 松枝智子

松枝智子マツエダサトコ